Spots Global Cancer Trial Database for Uterine Artery Occlusion for Fibroid Related Bleeding
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Uterine Artery Occlusion for Fibroid Related Bleeding
Official Title: An Evaluation of a Doppler-Guided Uterine Artery Occlusion Device as Treatment for the Reduction of Fibroid-Associated Bleeding
Study ID: NCT00496067
Interventions
Study Description
Brief Summary: The primary objective of this study is to evaluate the safety and effectiveness of Doppler guided Uterine Artery Occlusion (D-UAO) as treatment for the reduction of fibroid-associated symptoms.
Detailed Description: DUAO is intended for bilateral occlusion of the uterine arteries
Eligibility
Minimum Age: 25 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Viborg County Hospital, Viborg, , Denmark
University Hospital, Angers cedex, , France
Service de Gynecologie Obsterique, Hopital Antoine Beclere, Clamart Cedex, , France
Maternite les Bazennes, Dunkerque, , France
CHRU de Lille, Hopital Jeanne de Flandre, Lille Cedex, , France
Universitaeklinikum Erlangen, Erlangen, , Germany
Universitats-Frauenklinik Tubingen, Tubingen, , Germany
VU Medical Center, Amsterdam, , Netherlands
Ullevaal University, Oslo, , Norway
Universitats-Frauenklinik, Bern, , Switzerland
M1 Maternity, Bradford Royal Infirmary, Bradford, , United Kingdom
Hull and East Yorkshire Women & Children Hospital, Hull, , United Kingdom
Elizabeth Garret Anderson Hospital, London, , United Kingdom
Queen Elizabeth the Queen Mother Hospital, Margate, , United Kingdom
Contact Details
Name: David Robinson, MD
Affiliation: Ethicon, Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
